logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Z

Zhao Wang

capital medical university
H指数:24
被引数:3,217

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel adiposity indices and their associations with all-cause and cardiovascular mortality in individuals with cardiovascular–kidney–metabolic syndrome stages 0–3: findings from a nationwide prospective cohort study

新型肥胖指数及其与心血管-肾脏-代谢综合征0-3期个体全因死亡率和心血管死亡率的关系：一项全国性前瞻性队列研究的结果

Frontiers in Endocrinology
IF4.6
2025-10-070
OAAI
Hangyu Zhou; Yingying Xing; Tingting Wang; Tiantian Wang; Saiyaremu Xierzhati; Diliyaer Adili; Zhao Wang; Jie Li
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation
LEUKEMIA
IF13.4
2024-04-172
OAAI
Lu, Wenyi; Lyu, Hairong; Xiao, Xia; Bai, Xue; Zhang, Meng; Wang, Jiaxi; Pu, Yedi; Meng, Juanxia; Zhang, Xiaomei; Zhu, Haibo; Yuan, Ting; Wang, Bing; Jin, Xin; Cao, Xinping; Wang, Zhao; Xie, Tianle; Meng, Haotian; Stepanov, Alexey V.; Gabibov, Alexander G.; An, Yuxin; Sun, Rui; Zhang, Yu; Maschan, Mikhail A.; Zhu, Zunmin; Zhang, Hongkai; Zhao, Mingfeng
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial

Aponermin或安慰剂联合沙利度胺和地塞米松治疗复发或难治性多发性骨髓瘤 (CPT-MM301): 一项随机，双盲，安慰剂对照的3期试验

BMC CANCER
IF3.4
2023-10-1413
OAAI
Xia, Zhongjun; Leng, Yun; Fang, Baijun; Liang, Yang; Li, Wei; Fu, Chengcheng; Yang, Linhua; Ke, Xiaoyan; Jiang, Hua; Weng, Jianyu; Liu, Li; Zhao, Yaozhong; Zhang, Xuejun; Huang, Zhongxia; Liu, Aichun; Shi, Qingzhi; Gao, Yuhuan; Chen, Xiequn; Pan, Ling; Cai, Zhen; Wang, Zhao; Wang, Yafei; Fan, Yaqun; Hou, Ming; Ma, Yigai; Hu, Jianda; Liu, Jing; Zhou, Jianfeng; Zhang, Xiaohong; Meng, Haitao; Lu, Xuzhang; Li, Fei; Ren, Hanyun; Huang, Bintao; Shao, Zonghong; Zhou, Hebing; Hu, Yu; Yang, Shifang; Zheng, Xiangjun; Wei, Peng; Pang, Hongyan; Yu, Wei; Liu, Yuzhang; Gao, Sujun; Yan, Lingzhi; Ma, Yanping; Jing, Hongmei; Du, Juan; Ling, Wei; Zhang, Jingyi; Sui, Weiwei; Wang, Fuxu; Li, Xin; Chen, Wenming
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
CANCER BIOLOGY & MEDICINE
IF8.4
2023-03-026
OAAI
Li, Ping; Liu, Yang; Liang, Yun; Bo, Jian; Gao, Sujun; Hu, Yongxian; Hu, Yu; Huang, He; Huang, Xiaojun; Jing, Hongmei; Ke, Xiaoyan; Li, Jianyong; Li, Yuhua; Liu, Qifa; Lu, Peihua; Mei, Heng; Niu, Ting; Song, Yongping; Song, Yuqin; Su, Liping; Tu, Sanfang; Wang, Jianxiang; Wu, Depei; Wang, Zhao; Xu, Kailin; Ying, Zhitao; Yang, Qingming; Zhang, Yajing; Shi, Fengxia; Zhang, Bin; Zhang, Huilai; Zhang, Xi; Zhao, Mingfeng; Zhao, Weili; Zhao, Xiangyu; Huang, Liang; Zhu, Jun; Qian, Wenbin; Han, Weidong; Liang, Aibin

研究方向

暂未获取到该数据
Y
Yini Wang
H 指数:26论文数:211被引数:3,139
J
Jingshi Wang
H 指数:20论文数:200被引数:1,530
L
Lin Wu
H 指数:24论文数:234被引数:2,258
Z
Zhili Jin
H 指数:10论文数:47被引数:443
J
Jia Zhang
H 指数:30论文数:291被引数:3,067
N
Na Wei
H 指数:27论文数:169被引数:2,022
Y
Yue Song
H 指数:17论文数:79被引数:874
L
Lingbo He
H 指数:7论文数:32被引数:128
Z
Zhengjie Hua
H 指数:6论文数:21被引数:113
S
Shuyan Yao
H 指数:7论文数:25被引数:171